Maribavir
Who holds supplier records for Maribavir? 5 organisations hold a current record for Maribavir: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (4) and China (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Maribavir: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/maribavir
Reading the evidence
- 5 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
4 of the 5 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Maribavir expires 11 Oct 2043. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (5)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Maribavir. Country is the organisation's recorded country, not necessarily the manufacturing site.
- HONOUR LAB LTDIndia Company GMP cert on recordActive DMF 40330 · latest filing Apr 2025
- MAITHRI DRUGS PRIVATE LTDIndia Company GMP cert on recordActive DMF 42694 · latest filing Sept 2025
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 41616 · latest filing Mar 2025
- Qilu Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 42071 · latest filing Jun 2025
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 42422 · latest filing Sept 2025
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (1 listed product contain Maribavir). The latest listed patent expires 11 Oct 2043. The latest listed exclusivity runs to 23 Nov 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Maribavir is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL515408).
Chemical identity
- IUPAC name
- (2S,3S,4R,5S)-2-[5,6-dichloro-2-(propan-2-ylamino)benzimidazol-1-yl]-5-(hydroxymethyl)oxolane-3,4-diol
- Canonical SMILES
- CC(C)NC1=NC2=CC(=C(C=C2N1[C@@H]3[C@H]([C@H]([C@@H](O3)CO)O)O)Cl)Cl
- InChIKey
- KJFBVJALEQWJBS-XUXIUFHCSA-N
- Synonyms
- 1263-W-94, 1263W94, BW-1263W94, GW-257406X, Livtencity, Maribavir, Benzimidavir, Camvia, GW-1263, BW 1263W94, GW257406X, GW 1263
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Cytomegalovirus pUL97 Kinase Inhibitor
- Mechanism of action
- Breast Cancer Resistance Protein Inhibitors; Cytochrome P450 3A4 Inhibitors; Cytomegalovirus pUL97 Kinase Inhibitors; P-Glycoprotein Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Maribavir?
5 organisations hold an active US FDA Type II Drug Master File or a CEP for Maribavir: HONOUR LAB LTD (India), MAITHRI DRUGS PRIVATE LTD (India), MSN LIFE SCIENCES PRIVATE LIMITED (India), Qilu Pharmaceutical Co., Ltd. (China) and Sun Pharmaceutical Industries Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Maribavir Drug Master Files are active?
HONOUR LAB LTD (DMF 40330), MAITHRI DRUGS PRIVATE LTD (DMF 42694), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 41616), Qilu Pharmaceutical Co., Ltd. (DMF 42071) and Sun Pharmaceutical Industries Limited (DMF 42422). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does the FDA Orange Book list patents for products containing Maribavir?
Yes. The latest patent listed for an approved US product containing Maribavir expires 11 Oct 2043, across 1 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Maribavir supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Maribavir?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.